Organization
Longeveron
6 clinical trials
Clinical trial
Lomecel-B Effects on Alzheimer's Disease: A Randomized, Double-Blinded, Placebo-Controlled Phase 2a TrialStatus: Completed, Estimated PCD: 2023-09-29
Clinical trial
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS) : A Phase IIb Clinical Trial.Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Phase 1 Double-blinded, Randomized, Placebo-controlled Study for COVID-19 and Influenza Virus-Elicited Acute Respiratory Distress Syndrome (ARDS) Using Lomecel-BStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Efficacy of Allogeneic Human Mesenchymal Stem Cells in Patients With Metabolic Syndrome.Status: Withdrawn, Estimated PCD: 2023-12-01
Clinical trial
Effects of Intravenous Delivery of Lomecel-B (Formerly Allogenic Longeveron Human Mesenchymal Stem Cells (LMSCs)) on VaccinE-Specific Antibody Responses in Subjects With Aging FrailtyStatus: Completed, Estimated PCD: 2021-09-01
Clinical trial
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)Status: Active (not recruiting), Estimated PCD: 2024-06-30